×

Gilead earnings blowout: Pro

4:09 PM ET Tue, 22 April 2014

Providing instant analysis to Gilead and Amgen's quarterly numbers, with David Nelson, Belpointe Asset Management, and CNBC's Sharon Epperson and Kate Kelly.